|3 BC. Hubert Curien, BP13562, 31035 Cedex1 Toulouse, FRANCE
+ 33 (0)5 34 50 66 00
The manufacturing injectable products is a major focus of the offer OPHRDC Pierre Fabre.
Since 1991 on its plant in Pau, Pierre Fabre manufactures injectable way for the world market (EU - USA - Japan-Brazil ....), using aseptic processing or terminal sterilization.
Our expertise :
- Automatic loading and unloading of freeze dryers
- RABS and isolators
- Capping Class A / D with RABS and A / C with insulators
- Risk analysis of manufacturing processes
- Aseptic preparation in total or partial depending on the product
Our workshops :
- 8 bottles filling lines
- 1 syringe filling line
- 5 lyophilizers
- Bottles of 1 50 ml ml
- Needle 1 20 ml ml
- Lots of 10,000 200,000 to bottles
These production facilities enable our clients to overcome the quality problems related to the development of international standards and regulations. Pierre Fabre OPHRDC is able to study for its customers all of their manufacturing processes, primary and secondary packaging and to offer processes and scale-up improvements.
Pierre Fabre OPHRDC is recognized as a world leader for its anti-cancer injectables manufacturing capabilities (cytotoxic agents, monoclonal antibodies, ADC, vaccines, etc.) and now makes available to its partners its development capabilities. Thus, Pierre Fabre CDMO offers a range of shaping injectables lots (pre) clinical to commercial lots.
With over 24 years experience on two production sites, Pierre Fabre OPHRDC is able to offer its partners the best knowledge in the production of highly active molecules in vials in liquid or lyophilized form, or syringes.